These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


235 related items for PubMed ID: 18500561

  • 21. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC.
    Shoaib MH, Tazeen J, Merchant HA, Yousuf RI.
    Pak J Pharm Sci; 2006 Apr; 19(2):119-24. PubMed ID: 16751122
    [Abstract] [Full Text] [Related]

  • 22. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
    Sankalia JM, Sankalia MG, Mashru RC.
    J Control Release; 2008 Jul 02; 129(1):49-58. PubMed ID: 18456362
    [Abstract] [Full Text] [Related]

  • 23. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac.
    Kumar D, Sailaja Chirravuri SV, Shastri NR.
    Int J Pharm; 2014 Jan 30; 461(1-2):459-68. PubMed ID: 24368106
    [Abstract] [Full Text] [Related]

  • 24. Multiparticulate drug delivery system of aceclofenac: development and in vitro studies.
    Shavi GV, Nayak U, Averineni RK, Arumugam K, Meka SR, Nayanabhirama U, Sureshwar P.
    Drug Dev Ind Pharm; 2009 Feb 30; 35(2):252-8. PubMed ID: 18798090
    [Abstract] [Full Text] [Related]

  • 25. Comparative study of propranolol hydrochloride release from matrix tablets with KollidonSR or hydroxy propyl methyl cellulose.
    Sahoo J, Murthy PN, Biswal S, Sahoo SK, Mahapatra AK.
    AAPS PharmSciTech; 2008 Feb 30; 9(2):577-82. PubMed ID: 18459050
    [Abstract] [Full Text] [Related]

  • 26. Formulation and Development of Novel Sulfasalazine Bilayer Tablets for The Treatment of Arthritis Associated With IBD: In-vitro and In-vivo Investigations.
    Jadiya S, Upmanyu N, Sathiyanarayanan A, Jain V, Dubey R, Buwade P.
    J Pharm Sci; 2024 Jul 30; 113(7):1919-1926. PubMed ID: 38401631
    [Abstract] [Full Text] [Related]

  • 27. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL, Lin SY, Lin YK, Ho HO, Lo YW, Sheu MT.
    Eur J Pharm Biopharm; 2008 Sep 30; 70(1):289-301. PubMed ID: 18539015
    [Abstract] [Full Text] [Related]

  • 28. Controlled release of dual drug-loaded hydroxypropyl methylcellulose matrix tablet using drug-containing polymeric coatings.
    Lee BJ, Ryu SG, Cui JH.
    Int J Pharm; 1999 Oct 15; 188(1):71-80. PubMed ID: 10528084
    [Abstract] [Full Text] [Related]

  • 29. Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro/in vivo evaluation.
    Aburahma MH, Mahmoud AA.
    AAPS PharmSciTech; 2011 Dec 15; 12(4):1335-47. PubMed ID: 21979886
    [Abstract] [Full Text] [Related]

  • 30. Variables influencing drug release from layered matrix system comprising hydroxypropyl methylcellulose.
    Phaechamud T.
    AAPS PharmSciTech; 2008 Dec 15; 9(2):668-74. PubMed ID: 18500559
    [Abstract] [Full Text] [Related]

  • 31. Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan-based solvent change approach.
    Mutalik S, Anju P, Manoj K, Usha AN.
    Int J Pharm; 2008 Feb 28; 350(1-2):279-90. PubMed ID: 17945447
    [Abstract] [Full Text] [Related]

  • 32. Optimization of budesonide compression-coated tablets for colonic delivery.
    Yehia SA, Elshafeey AH, Sayed I, Shehata AH.
    AAPS PharmSciTech; 2009 Feb 28; 10(1):147-57. PubMed ID: 19199041
    [Abstract] [Full Text] [Related]

  • 33. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
    Vueba ML, Batista de Carvalho LA, Veiga F, Sousa JJ, Pina ME.
    Drug Dev Ind Pharm; 2013 Nov 28; 39(11):1651-62. PubMed ID: 23094867
    [Abstract] [Full Text] [Related]

  • 34. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
    Zugasti ME, Zornoza A, Goñi Mdel M, Isasi JR, Vélaz I, Martín C, Sánchez M, Martínez-Ohárriz MC.
    Drug Dev Ind Pharm; 2009 Oct 28; 35(10):1264-70. PubMed ID: 19555243
    [Abstract] [Full Text] [Related]

  • 35. Sustained release of acetaminophen from a heterogeneous mixture of two hydrophilic non-ionic cellulose ether polymers.
    Ebube NK, Jones AB.
    Int J Pharm; 2004 Mar 19; 272(1-2):19-27. PubMed ID: 15019065
    [Abstract] [Full Text] [Related]

  • 36. Design and in vitro and in vivo characterization of mucoadhesive matrix pellets of metformin hydrochloride for oral controlled release: a technical note.
    Ige PP, Gattani SG.
    Arch Pharm Res; 2012 Mar 19; 35(3):487-98. PubMed ID: 22477196
    [Abstract] [Full Text] [Related]

  • 37. Floating elementary osmotic pump tablet (FEOPT) for controlled delivery of diethylcarbamazine citrate: a water-soluble drug.
    Khan ZA, Tripathi R, Mishra B.
    AAPS PharmSciTech; 2011 Dec 19; 12(4):1312-23. PubMed ID: 21969244
    [Abstract] [Full Text] [Related]

  • 38. Preparation and evaluation of chitosan/carrageenan beads for controlled release of sodium diclofenac.
    Piyakulawat P, Praphairaksit N, Chantarasiri N, Muangsin N.
    AAPS PharmSciTech; 2007 Nov 16; 8(4):E97. PubMed ID: 18181557
    [Abstract] [Full Text] [Related]

  • 39. Biopharmaceutical evaluation of diclofenac sodium controlled release tablets prepared from gum karaya--chitosan polyelectrolyte complexes.
    Lankalapalli S, Kolapalli RM.
    Drug Dev Ind Pharm; 2012 Jul 16; 38(7):815-24. PubMed ID: 22087874
    [Abstract] [Full Text] [Related]

  • 40. Design and in vivo evaluation of oxycodone once-a-day controlled-release tablets.
    Kim JY, Lee SH, Park CW, Rhee YS, Kim DW, Park J, Lee M, Seo JW, Park ES.
    Drug Des Devel Ther; 2015 Jul 16; 9():695-706. PubMed ID: 25678774
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.